BioNTech BNTX Delivers Q1 2026 Beat EPS 210 vs 227 Expected Tech Stocks Slide as Nvidia Earnings Approach and Samsung Strike Looms Marvell Technologys Optical Interconnect Push May Unlock New Growth Opportunities Garrick Higgo Hit With TwoStroke Penalty at PGA Championship Potential Impact on Performance and Prize Money Midland MSBIP Holds 2539 Direction Awaited 20260520 Alpine PINE Stock Down 068 Support Test at 1803 20260521 TE TEL Q1 2026 Earnings Surprise EPS 273 Up Significant Meta CEO Zuckerberg Tells Employees No Further CompanyWide Layoffs Expected This Year Wind Repowering A Potential Catalyst for Renewable Energy Growth CoPays For GLP1 Weight Loss Drugs Set to Rise Amid Coverage Challenges Procter Gamble Hygiene Q4 Net Profit Flat at 156 Crore Board Declares 60Share Final Dividend Microsoft Appoints Jenny LayFlurrie to Lead Responsible AI Development at Scale Skilled Trade Dilemma The Real Reasons Behind the Electrician Shortage OpenAI Prepares for IPO Filing Sources Say FITBI Q1 2026 Earnings EPS Surges Past Estimates Modest Stock Response Astera Labs Inc ALAB Q1 2026 Earnings EPS Surpasses Estimates as Shares Climb YALA Q1 2026 Earnings Positive EPS of 016 Drives Modest Share Uptick VELO Q1 2026 Earnings Significant EPS Beat Drives Stock Surge JSM Q1 2026 Earnings Navient Beats EPS Estimates by 2225 Note Price Unchanged NWE Q1 2026 Earnings EPS Beat Fails to Impress Shares Edge Lower Tri Pointe Homes Holds Steady Near Support Amid Consolidation Century Therapeutics IPSC Holds Near Support After Modest Decline SR Bancorp SRBK Surges Over 2 as Bulls Test Key Resistance at 1964 Viper Energy Holds Steady Near Support Amid Modest Decline DarioHealth DRIO Sheds 116 as Stock Tests Key Support Levels Microsoft Appoints Jenny LayFlurrie to Lead Trusted Tech Amid AI Development Speed Concerns Cartesian Therapeutics Inc RNAC Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Stock Ticks Higher Shake Shack SHAK Surges Over 4 as Shares Test Key Resistance Delhivery Q4FY26 Net Profit Nearly Flat at 724 Crore Despite 30 Revenue Surge Neumora Therapeutics NMRA Q1 2026 Earnings Beat Revenue NA EPS 030 Tripcom TCOM Crushes Q4 2025 Estimates EPS 497 Tops Views Paul Tudor Jones No Chance Warsh Will Cut Interest Rates Kiora Pharmaceuticals KPRX Q1 2026 Earnings Why the Beat Matters Elon Musk Loses OpenAI Lawsuit as Jury Rules Statute of Limitations Expired Electromed ELMD Reports Strong Q1 2026 Revenue NA EPS Beats